Traders revive antitrust complaint against Robinhood and Citadel Securities
Robinhood and Citadel are accused of having hatched an anticompetitive scheme to restrict retail investors’ access to specific stocks.
Robinhood and Citadel are accused of having hatched an anticompetitive scheme to restrict retail investors’ access to specific stocks.
Citadel Securities’s risk management controls were not reasonably designed to prevent the entry of erroneous orders.
The plaintiffs in a short squeeze lawsuit targeting companies such as Robinhood and Citadel need more time to draft an amended antitrust complaint.
The Court has found that traders embroiled in the January trading short squeeze have failed to plead conspiracy.
According to the traders, Citadel mischaracterizes the SEC’s Report and cherry picks portions that expand its arguments.
Citadel Securities, which is accused of participating in market conspiracy that led to the January short squeeze events, refers to SEC report.
Citadel argues that the traders have utterly failed to plead a cognizable antitrust claim that can survive a motion to dismiss.
Citadel Securities claims that the conspiracy theory at the heart of a “short squeeze” lawsuit brought by traders rings hollow.
FINRA fines Citadel Securities for multiple issues with correctly reporting Treasury transactions to TRACE.
Citadel Securities has agreed to a censure and a $180,000 fine to settle the matter with FINRA.